|
2021-11-12 |
2021-11-11 |
VP
Vente planifiée
|
Ladone Mary Kay
SVP, Corp. Dev., Strat. & IR
Dirigeant
|
2 018
-52.3%
155,14
313 073 USD
|
2 018
-52.3%
|
155,14
|
313 073 USD
|
|
|
2021-11-10 |
2021-11-08 |
VP
Vente planifiée
|
Ladone Mary Kay
SVP, Corp. Dev., Strat. & IR
Dirigeant
|
2 051
-100.0%
155,08
318 069 USD
|
2 051
-100.0%
|
155,08
|
318 069 USD
|
|
|
2021-11-10 |
2021-11-08 |
VP
Vente planifiée
|
Ladone Mary Kay
SVP, Corp. Dev., Strat. & IR
Dirigeant
|
872
-100.0%
155,08
135 230 USD
|
872
-100.0%
|
155,08
|
135 230 USD
|
|
|
2021-06-11 |
2021-06-10 |
VP
Vente planifiée
|
Rasin Deborah
SVP, Chief Legal Officer
Dirigeant
|
1 267
-6.0%
114,12
144 594 USD
|
1 267
-6.0%
|
114,12
|
144 594 USD
|
|
|
2021-06-11 |
2021-06-10 |
VP
Vente planifiée
|
Rasin Deborah
SVP, Chief Legal Officer
Dirigeant
|
1 833
-8.0%
113,49
208 027 USD
|
1 833
-8.0%
|
113,49
|
208 027 USD
|
|
|
2021-06-11 |
2021-06-10 |
VP
Vente planifiée
|
Rasin Deborah
SVP, Chief Legal Officer
Dirigeant
|
1 900
-7.6%
112,57
213 883 USD
|
1 900
-7.6%
|
112,57
|
213 883 USD
|
|
|
2021-06-09 |
2021-06-07 |
VP
Vente planifiée
|
Rasin Deborah
SVP, Chief Legal Officer
Dirigeant
|
659
-2.6%
111,26
73 318 USD
|
659
-2.6%
|
111,26
|
73 318 USD
|
|
|
2021-06-09 |
2021-06-07 |
VP
Vente planifiée
|
Rasin Deborah
SVP, Chief Legal Officer
Dirigeant
|
2 564
-9.1%
110,52
283 363 USD
|
2 564
-9.1%
|
110,52
|
283 363 USD
|
|
|
2021-06-09 |
2021-06-07 |
VP
Vente planifiée
|
Rasin Deborah
SVP, Chief Legal Officer
Dirigeant
|
601
-2.4%
111,24
66 855 USD
|
601
-2.4%
|
111,24
|
66 855 USD
|
|
|
2021-06-09 |
2021-06-07 |
VP
Vente planifiée
|
Rasin Deborah
SVP, Chief Legal Officer
Dirigeant
|
2 399
-8.6%
110,52
265 140 USD
|
2 399
-8.6%
|
110,52
|
265 140 USD
|
|
|
2021-06-09 |
2021-06-07 |
VP
Vente planifiée
|
Rasin Deborah
SVP, Chief Legal Officer
Dirigeant
|
454
-1.6%
111,25
50 508 USD
|
454
-1.6%
|
111,25
|
50 508 USD
|
|
|
2021-06-09 |
2021-06-07 |
VP
Vente planifiée
|
Rasin Deborah
SVP, Chief Legal Officer
Dirigeant
|
1 546
-5.2%
110,52
170 861 USD
|
1 546
-5.2%
|
110,52
|
170 861 USD
|
|
|
2021-06-09 |
2021-06-07 |
VP
Vente planifiée
|
Rasin Deborah
SVP, Chief Legal Officer
Dirigeant
|
488
-1.6%
111,21
54 272 USD
|
488
-1.6%
|
111,21
|
54 272 USD
|
|
|
2021-06-09 |
2021-06-07 |
VP
Vente planifiée
|
Rasin Deborah
SVP, Chief Legal Officer
Dirigeant
|
1 512
-4.7%
110,51
167 091 USD
|
1 512
-4.7%
|
110,51
|
167 091 USD
|
|
|
2020-10-28 |
2020-10-26 |
VP
Vente planifiée
|
FRANK ANDREAS G
SVP, Pres. Front Line Care
Dirigeant
|
5 500
-31.2%
91,45
502 975 USD
|
5 500
-31.2%
|
91,45
|
502 975 USD
|
|
|
2020-10-21 |
2020-10-19 |
VP
Vente planifiée
|
FRANK ANDREAS G
SVP, Pres. Front Line Care
Dirigeant
|
5 500
-23.8%
89,90
494 450 USD
|
5 500
-23.8%
|
89,90
|
494 450 USD
|
|
|
2020-10-14 |
2020-10-12 |
VP
Vente planifiée
|
FRANK ANDREAS G
SVP, Pres. Front Line Care
Dirigeant
|
5 500
-19.2%
89,48
492 140 USD
|
5 500
-19.2%
|
89,48
|
492 140 USD
|
|
|
2020-10-08 |
2020-10-06 |
VP
Vente planifiée
|
FRANK ANDREAS G
SVP, Pres. Front Line Care
Dirigeant
|
5 500
-16.1%
87,50
481 250 USD
|
5 500
-16.1%
|
87,50
|
481 250 USD
|
|
|
2020-07-02 |
2020-06-30 |
VP
Vente planifiée
|
Ladone Mary Kay
SVP, Corp. Dev., Strat. & IR
Dirigeant
|
2 278
-21.8%
110,00
250 580 USD
|
2 278
-21.8%
|
110,00
|
250 580 USD
|
|
|
2020-06-08 |
2020-06-05 |
VP
Vente planifiée
|
Rasin Deborah
SVP, Chief Legal Officer
Dirigeant
|
3 795
-12.5%
102,81
390 164 USD
|
3 795
-12.5%
|
102,81
|
390 164 USD
|
|
|
2020-06-08 |
2020-06-05 |
VP
Vente planifiée
|
Rasin Deborah
SVP, Chief Legal Officer
Dirigeant
|
3 222
-10.8%
102,81
331 254 USD
|
3 222
-10.8%
|
102,81
|
331 254 USD
|
|
|
2020-06-08 |
2020-06-05 |
VP
Vente planifiée
|
Johnson Paul Sherwood
SVP & Pres. - PSS Acute Care
Dirigeant
|
2 258
-100.0%
104,91
236 885 USD
|
2 258
-100.0%
|
104,91
|
236 885 USD
|
|
|
2020-06-08 |
2020-06-05 |
VP
Vente planifiée
|
Johnson Paul Sherwood
SVP & Pres. - PSS Acute Care
Dirigeant
|
2 741
-54.8%
104,42
286 212 USD
|
2 741
-54.8%
|
104,42
|
286 212 USD
|
|
|
2020-06-08 |
2020-06-05 |
VP
Vente planifiée
|
Rasin Deborah
SVP, Chief Legal Officer
Dirigeant
|
1 800
-6.4%
102,81
185 058 USD
|
1 800
-6.4%
|
102,81
|
185 058 USD
|
|
|
2020-06-08 |
2020-06-05 |
VP
Vente planifiée
|
Johnson Paul Sherwood
SVP & Pres. - PSS Acute Care
Dirigeant
|
5 345
-51.7%
103,30
552 117 USD
|
5 345
-51.7%
|
103,30
|
552 117 USD
|
|
|
2020-04-09 |
2020-04-07 |
VP
Vente planifiée
|
Dodrill Amy M.
President - Surgical Solutions
Dirigeant
|
905
-39.5%
110,00
99 550 USD
|
905
-39.5%
|
110,00
|
99 550 USD
|
|
|
2020-04-09 |
2020-04-07 |
VP
Vente planifiée
|
Dodrill Amy M.
President - Surgical Solutions
Dirigeant
|
986
-41.5%
110,00
108 460 USD
|
986
-41.5%
|
110,00
|
108 460 USD
|
|
|
2020-04-09 |
2020-04-07 |
VP
Vente planifiée
|
Dodrill Amy M.
President - Surgical Solutions
Dirigeant
|
1 298
-48.3%
110,00
142 780 USD
|
1 298
-48.3%
|
110,00
|
142 780 USD
|
|
|
2019-12-02 |
2019-11-27 |
V
Vente
|
FRANK ANDREAS G
SVP, Pres. Front Line Care
Dirigeant
|
6 000
-15.0%
106,67
640 008 USD
|
6 000
-15.0%
|
106,67
|
640 008 USD
|
|
|
2019-11-13 |
2019-11-12 |
V
Vente
|
Rasin Deborah
SVP, Chief Legal Officer
Dirigeant
|
4 739
-15.3%
103,97
492 714 USD
|
4 739
-15.3%
|
103,97
|
492 714 USD
|
|
|
2019-08-16 |
2019-08-14 |
V
Vente
|
Johnson Paul Sherwood
SVP & Pres. - PSS Acute Care
|
2 095
-31.5%
104,33
218 580 USD
|
2 095
-31.5%
|
104,33
|
218 580 USD
|
|
|
2019-08-16 |
2019-08-14 |
V
Vente
|
Johnson Paul Sherwood
SVP & Pres. - PSS Acute Care
|
724
-13.7%
104,39
75 579 USD
|
724
-13.7%
|
104,39
|
75 579 USD
|
|
|
2019-08-16 |
2019-08-14 |
V
Vente
|
Johnson Paul Sherwood
SVP & Pres. - PSS Acute Care
|
100
-2.1%
104,34
10 434 USD
|
100
-2.1%
|
104,34
|
10 434 USD
|
|
|
2019-08-16 |
2019-08-14 |
V
Vente
|
Johnson Paul Sherwood
SVP & Pres. - PSS Acute Care
|
100
-2.1%
104,29
10 429 USD
|
100
-2.1%
|
104,29
|
10 429 USD
|
|
|
2019-08-16 |
2019-08-14 |
V
Vente
|
Johnson Paul Sherwood
SVP & Pres. - PSS Acute Care
|
100
-2.1%
104,28
10 428 USD
|
100
-2.1%
|
104,28
|
10 428 USD
|
|
|
2019-08-16 |
2019-08-14 |
V
Vente
|
Johnson Paul Sherwood
SVP & Pres. - PSS Acute Care
|
81
-1.6%
104,26
8 445 USD
|
81
-1.6%
|
104,26
|
8 445 USD
|
|
|
2019-08-16 |
2019-08-14 |
V
Vente
|
Johnson Paul Sherwood
SVP & Pres. - PSS Acute Care
|
85
-1.7%
104,24
8 861 USD
|
85
-1.7%
|
104,24
|
8 861 USD
|
|
|
2019-08-16 |
2019-08-14 |
V
Vente
|
Johnson Paul Sherwood
SVP & Pres. - PSS Acute Care
|
200
-3.8%
104,24
20 848 USD
|
200
-3.8%
|
104,24
|
20 848 USD
|
|
|
2019-08-16 |
2019-08-14 |
V
Vente
|
Johnson Paul Sherwood
SVP & Pres. - PSS Acute Care
|
100
-1.9%
104,24
10 424 USD
|
100
-1.9%
|
104,24
|
10 424 USD
|
|
|
2019-08-16 |
2019-08-14 |
V
Vente
|
Johnson Paul Sherwood
SVP & Pres. - PSS Acute Care
|
100
-1.8%
104,23
10 423 USD
|
100
-1.8%
|
104,23
|
10 423 USD
|
|
|
2019-08-16 |
2019-08-14 |
V
Vente
|
Johnson Paul Sherwood
SVP & Pres. - PSS Acute Care
|
100
-1.8%
104,21
10 421 USD
|
100
-1.8%
|
104,21
|
10 421 USD
|
|
|
2019-08-16 |
2019-08-14 |
V
Vente
|
Johnson Paul Sherwood
SVP & Pres. - PSS Acute Care
|
100
-1.8%
104,17
10 417 USD
|
100
-1.8%
|
104,17
|
10 417 USD
|
|
|
2019-08-16 |
2019-08-14 |
V
Vente
|
Johnson Paul Sherwood
SVP & Pres. - PSS Acute Care
|
2 585
-31.5%
104,16
269 264 USD
|
2 585
-31.5%
|
104,16
|
269 264 USD
|
|
|
2019-08-09 |
2019-08-07 |
V
Vente
|
Rasin Deborah
SVP, Chief Legal Officer
|
3 795
-16.5%
103,00
390 885 USD
|
3 795
-16.5%
|
103,00
|
390 885 USD
|
|
|
2019-08-09 |
2019-08-07 |
V
Vente
|
Rasin Deborah
SVP, Chief Legal Officer
|
1 705
-8.1%
103,00
175 615 USD
|
1 705
-8.1%
|
103,00
|
175 615 USD
|
|
|
2018-11-30 |
2018-11-28 |
V
Vente
|
FRANK ANDREAS G
SVP, Chief Transformation Off
Dirigeant
|
5 518
-17.9%
95,73
528 238 USD
|
5 518
-17.9%
|
95,73
|
528 238 USD
|
|
|
2018-11-30 |
2018-11-28 |
V
Vente
|
FRANK ANDREAS G
SVP, Chief Transformation Off
Dirigeant
|
1 936
-7.1%
95,83
185 531 USD
|
1 936
-7.1%
|
95,83
|
185 531 USD
|
|
|
2018-06-13 |
2018-06-11 |
VP
Vente planifiée
|
SHADER ALTON
SVP, Pres. of Welch Allyn
Dirigeant
|
400
-0.8%
94,17
37 669 USD
|
400
-0.8%
|
94,17
|
37 669 USD
|
|
|
2018-06-13 |
2018-06-11 |
VP
Vente planifiée
|
SHADER ALTON
SVP, Pres. of Welch Allyn
Dirigeant
|
7 339
-12.5%
93,71
687 760 USD
|
7 339
-12.5%
|
93,71
|
687 760 USD
|
|
|
2018-06-13 |
2018-06-11 |
VP
Vente planifiée
|
SHADER ALTON
SVP, Pres. of Welch Allyn
Dirigeant
|
300
-0.6%
94,22
28 267 USD
|
300
-0.6%
|
94,22
|
28 267 USD
|
|
|
2018-06-13 |
2018-06-11 |
VP
Vente planifiée
|
SHADER ALTON
SVP, Pres. of Welch Allyn
Dirigeant
|
4 785
-8.5%
93,65
448 096 USD
|
4 785
-8.5%
|
93,65
|
448 096 USD
|
|
|
2018-06-13 |
2018-06-11 |
VP
Vente planifiée
|
SHADER ALTON
SVP, Pres. of Welch Allyn
Dirigeant
|
300
-0.6%
94,19
28 256 USD
|
300
-0.6%
|
94,19
|
28 256 USD
|
|
|
2018-06-13 |
2018-06-11 |
VP
Vente planifiée
|
SHADER ALTON
SVP, Pres. of Welch Allyn
Dirigeant
|
3 688
-6.7%
93,59
345 160 USD
|
3 688
-6.7%
|
93,59
|
345 160 USD
|
|
|
2018-05-30 |
2018-05-25 |
V
Vente
|
Johnson Paul Sherwood
SVP & Pres. - PSS Acute Care
Dirigeant
|
2 171
-67.1%
90,87
197 283 USD
|
2 171
-67.1%
|
90,87
|
197 283 USD
|
|
|
2018-05-30 |
2018-05-25 |
V
Vente
|
Johnson Paul Sherwood
SVP & Pres. - PSS Acute Care
Dirigeant
|
2 997
-73.8%
90,88
272 361 USD
|
2 997
-73.8%
|
90,88
|
272 361 USD
|
|
|
2018-04-16 |
2018-04-12 |
VP
Vente planifiée
|
Rasin Deborah
SVP, Chief Legal Officer
Dirigeant
|
3 795
-27.1%
86,02
326 446 USD
|
3 795
-27.1%
|
86,02
|
326 446 USD
|
|
|
2018-04-16 |
2018-04-12 |
VP
Vente planifiée
|
Rasin Deborah
SVP, Chief Legal Officer
Dirigeant
|
3 795
-27.1%
86,02
326 446 USD
|
3 795
-27.1%
|
86,02
|
326 446 USD
|
|
|
2017-12-15 |
2017-12-15 |
VP
Vente planifiée
|
GREISCH JOHN J
Chief Executive Officer
Administrateur exécutif
|
25 241
-9.9%
82,04
2 070 772 USD
|
25 241
-9.9%
|
82,04
|
2 070 772 USD
|
|
|
2017-12-15 |
2017-12-14 |
VP
Vente planifiée
|
GREISCH JOHN J
Chief Executive Officer
Administrateur exécutif
|
9 100
-3.8%
82,94
754 754 USD
|
9 100
-3.8%
|
82,94
|
754 754 USD
|
|
|
2017-12-15 |
2017-12-14 |
VP
Vente planifiée
|
GREISCH JOHN J
Chief Executive Officer
Administrateur exécutif
|
40 900
-14.6%
82,09
3 357 481 USD
|
40 900
-14.6%
|
82,09
|
3 357 481 USD
|
|
|
2017-12-15 |
2017-12-13 |
V
Vente
|
Johnson Paul Sherwood
SVP & Pres. - PSS Acute Care
|
1 000
-48.4%
82,99
82 990 USD
|
1 000
-48.4%
|
82,99
|
82 990 USD
|
|
|
2017-12-15 |
2017-12-13 |
VP
Vente planifiée
|
GREISCH JOHN J
Chief Executive Officer
Administrateur exécutif
|
27 771
-10.7%
83,46
2 317 768 USD
|
27 771
-10.7%
|
83,46
|
2 317 768 USD
|
|
|
2017-12-15 |
2017-12-13 |
VP
Vente planifiée
|
GREISCH JOHN J
Chief Executive Officer
Administrateur exécutif
|
22 229
-7.9%
82,93
1 843 451 USD
|
22 229
-7.9%
|
82,93
|
1 843 451 USD
|
|
|
2017-12-13 |
2017-12-12 |
VP
Vente planifiée
|
GREISCH JOHN J
Chief Executive Officer
Administrateur exécutif
|
1 743
-0.7%
83,38
145 331 USD
|
1 743
-0.7%
|
83,38
|
145 331 USD
|
|
|
2017-12-13 |
2017-12-12 |
VP
Vente planifiée
|
GREISCH JOHN J
Chief Executive Officer
Administrateur exécutif
|
48 257
-17.2%
82,68
3 989 889 USD
|
48 257
-17.2%
|
82,68
|
3 989 889 USD
|
|
|
2017-12-13 |
2017-12-11 |
VP
Vente planifiée
|
GREISCH JOHN J
Chief Executive Officer
Administrateur exécutif
|
13 921
-5.7%
82,94
1 154 608 USD
|
13 921
-5.7%
|
82,94
|
1 154 608 USD
|
|
|
2017-12-13 |
2017-12-11 |
VP
Vente planifiée
|
GREISCH JOHN J
Chief Executive Officer
Administrateur exécutif
|
36 079
-13.5%
82,93
2 992 031 USD
|
36 079
-13.5%
|
82,93
|
2 992 031 USD
|
|
|
2017-12-07 |
2017-12-05 |
A
Achat
|
Garrett Mary
|
300
+inf%
83,30
24 990 USD
|
300
+inf%
|
83,30
|
24 990 USD
|
|
|
2017-09-15 |
2017-09-14 |
V
Vente
|
FRANK ANDREAS G
SVP, Corporate Development
|
2 930
-20.4%
77,00
225 622 USD
|
2 930
-20.4%
|
77,00
|
225 622 USD
|
|
|
2017-09-15 |
2017-09-13 |
V
Vente
|
FRANK ANDREAS G
SVP, Corporate Development
|
2 313
-13.8%
77,72
179 773 USD
|
2 313
-13.8%
|
77,72
|
179 773 USD
|
|
|
2017-09-15 |
2017-09-13 |
V
Vente
|
FRANK ANDREAS G
SVP, Corporate Development
|
1 627
-8.9%
78,00
126 906 USD
|
1 627
-8.9%
|
78,00
|
126 906 USD
|
|
|
2017-06-08 |
2017-06-06 |
V
Vente
|
FRANK ANDREAS G
SVP, Corporate Development
|
4 160
-18.5%
78,54
326 706 USD
|
4 160
-18.5%
|
78,54
|
326 706 USD
|
|
|
2017-06-08 |
2017-06-06 |
V
Vente
|
FRANK ANDREAS G
SVP, Corporate Development
|
6 500
-22.4%
78,67
511 362 USD
|
6 500
-22.4%
|
78,67
|
511 362 USD
|
|
|
2017-05-19 |
2017-05-17 |
V
Vente
|
Johnson Paul Sherwood
SVP & Pres. - PSS Acute Care
Dirigeant
|
2 078
-100.0%
72,30
150 239 USD
|
2 078
-100.0%
|
72,30
|
150 239 USD
|
|
|
2017-05-17 |
2017-05-15 |
V
Vente
|
Richardson Jason
Corporate Controller
Dirigeant
|
359
-18.3%
73,51
26 390 USD
|
359
-18.3%
|
73,51
|
26 390 USD
|
|
